Epilepsy and the Microbiome: From Mechanisms to Potential Therapies

Source: International Probiotics Association

Epilepsy affects an estimated 50 million people worldwide, making it one of the most common neurological disorders—and one of the most unevenly treated. While many individuals achieve good seizure control with medication, a substantial proportion does not have access, particularly in low- and middle-income regions. Even in well-resourced settings, drug resistance and treatment side effects remain significant challenges. These gaps have prompted growing interest in factors beyond the brain itself.

This IPA blog explores the role of the gut microbiome in shaping seizure risk and treatment response.

Epilepsy and the Microbiome: From Mechanisms to Potential Therapies